Glucophage® Extended Release (XR) 750 Milligram (mg) Indonesia Bioequivalence (BE) Study
Status:
Completed
Trial end date:
2018-10-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess bioequivalence between metformin hydrochloride
(Glucophage® XR) manufactured in PT Merck Tbk, Indonesia (test drug) and metformin
hydrochloride (Glucophage® XR) manufactured in Merck Santé, France (comparator drug)
following single oral dose administration under fasting condition.